Pepgen announces appointment of howard mayer, m.d. to board of directors

Boston, nov. 15, 2023 (globe newswire) -- pepgen inc. (nasdaq: pepg), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced the appointment of howard mayer, m.d. to the pepgen board of directors, effective november 15, 2023.

PEPG Ratings Summary

PEPG Quant Ranking